Caves: Clinical Trials

2 trials of Caves, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 terminated. 2 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 12Terminated 2
Phase 21Terminated 1

Follow Caves: new trials by email Literature Review of Caves trials Research Report on Caves

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Intratumor Injection of Anti-Mesothelin Immunotoxin LMB-100 With Ipilimumab in Malignant Mesothelioma
LMB-100, ipilimumab, Diphenhydramine - Mesothelioma
Phase 1TerminatedNational Cancer Institute (NCI)22021-06-112024-02-02
Trial of EP0057, a Nanoparticle Camptothecin With Olaparib in People With Relapsed/Refractory Small Cell Lung Cancer
EP0057, olaparib, CT scan - Urothelial Carcinoma, Urothelial Cancer
Phase 1 / Phase 2TerminatedNational Cancer Institute (NCI)452016-05-092026-08-13

Conditions studied

Carcinoma, Transitional Cell (1)  ·  Lung Neoplasms (1)  ·  Mesothelioma (1)  ·  Prostatic Neoplasms (1)  ·  Small Cell Lung Carcinoma (1)

Sponsors

National Cancer Institute (NCI) (2)

Countries

United States (2)

Top investigators

Anish Thomas, M.D. (1)  ·  Raffit Hassan, M.D. (1)

Results publications

PMID 32897402, PMID 41425223, PMID 42820295